As of 12:30 PM on the 14th, EDGC is trading at 15,550 KRW, down 3.42% from the previous day. This represents a 38.22% increase compared to July 1. EDGC is known as a genomics analysis specialized company.
Over the past five days, individual investors have net purchased 78,720 shares, while foreigners and institutions have net sold 38,828 shares and net purchased 6,550 shares, respectively.
On July 13, EDGC became a market issue with the headline "COVID-19 diagnostic reagent expected to be No. 1 worldwide, soaring."
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
